Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-05-21

Clinical Trial Update: Role of Chemokines and Proinflammatory Cytokines in Rheumatoid Synovial Pathological Changes

View source ↗

Summary

The clinical trial examining chemokines and proinflammatory cytokines in rheumatoid synovial pathology has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Rheumatoid Arthritis | Status: WITHDRAWN